Microdosing GLP-1s

What is microdosing GLP-1s?

GLP-1 microdosing involves beginning treatment at a dose significantly lower than the conventional starting dose and increasing gradually when appropriate. For example, a customized semaglutide regimen may begin at 0.05 to 0.1 mg weekly rather than the commonly used 0.25 mg starting dose.

The goal is to help your body adapt gradually while supporting appetite regulation, insulin sensitivity, and metabolic health. Dr. Amersi individualizes treatment rather than basing it solely on reaching the highest possible dose.

When should I consider microdosing GLP-1s?

Microdosing may be considered for patients who are sensitive to medications, have experienced gastrointestinal side effects with GLP-1 therapy, or prefer a slower approach to metabolic and weight management. It may also be appropriate for some women with PCOS, insulin resistance, or weight changes associated with perimenopause and menopause.

Dr. Amersi completes a medical evaluation before starting or changing any GLP-1 medication.

What is it like to microdose GLP-1s?

Patients generally begin with a low dose and remain at that dose long enough for Dr. Amersi to evaluate tolerance, appetite, energy, hydration, and other symptoms. If additional treatment is needed and the medication is well tolerated, the dose may be increased gradually.

Dr. Amersi may continuously monitor various factors, including your weight, metabolic markers, symptoms, and other clinical factors. Her objective is to find the lowest effective dose that supports your individualized goals.

Who is microdosing best for?

Microdosing may be particularly useful for women with GI sensitivity, previous medication intolerance, insulin resistance, PCOS, or metabolic changes during hormonal transitions. It can also appeal to patients who want to combine GLP-1 therapy with nutrition, exercise, sleep, and other sustainable lifestyle strategies.

Is microdosing less effective?

Microdosing is not necessarily less effective for any particular patient. Because lower doses may be better tolerated, some patients may be able to remain on their treatment plan rather than stopping due to side effects. However, the effectiveness of a lower dose varies, and microdosing is not a substitute for evidence-based dosing when a higher dose is medically indicated.

Dr. Amersi can determine whether GLP-1 microdosing is appropriate based on your medical history, metabolic health, goals, and medication tolerance. Patients interested in a more personalized approach to weight management can call the office of Shamsah Amersi, MD, or request a consultation online today.